“treatment resistant depression”的搜索结果，显示 1721-1730 项，共有 6654 项

1. 失神发作- 症状与病因- 妙佑医疗国际

   Sign up for free and receive the latest on epilepsy treatment, care and management. I would like to learn more about: Latest on newly diagnosed epilepsy care.

2. 2019 冠状病毒病（COVID-19） - 诊断与治疗- 妙佑医疗国际

   Biologic License Application 125742. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/comirnaty. Accessed Sept. 25, 2025.

3. 起搏器- 医生与科室- 妙佑医疗国际

   Pacemaker. American Heart Association. https://www.heart.org/en/health-topics/arrhythmia/prevention--treatment-of-arrhythmia/pacemaker. Accessed Dec. 13 ...

4. 处方药滥用- 诊断与治疗- 妙佑医疗国际

   Journal of Substance Abuse Treatment. 2020; doi: 10.1016/j.jsat. 2020.108013 . Disposal of unused medicines: What you should know. U.S. Food and Drug ...

5. 睾丸癌- 医生与科室- 妙佑医疗国际

   Chemotherapy, Immunotherapy, PSMA therapy, Chemotherapy for ... An error occurred, please try again later. Copy for customer care: session ID undefined.

6. 急性呼吸窘迫综合征（ARDS） - 症状与病因- 妙佑医疗国际

   Acute hypoxemic respiratory failure (AHRF, ARDS). Merck Manual Professional Version. https://www.merckmanuals.com/professional/critical-care-medicine/ ...

7. 外科 - 临床试验- 妙佑医疗国际

   ... care for spinal deformity patients. Early Outcomes of Volar Capsulodesis for the Treatment of Scapholunate Ligament Injury. Rochester, Minn. The purpose of ...

8. 外科 - 临床试验- 妙佑医疗国际

   The primary purpose of this study is to evaluate the effectiveness of non-fusion surgical treatment of Spinal Deformity Correction in Adolescent Idiopathic ...

9. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with ...

10. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...